David is the Chief Strategy Officer and President Asia Pacific at Nanosonics Limited, and is a Non Executive Director of Technion Australia.
David has extensive experience in healthcare and medical devices, having served as the CEO and Managing Director of the Monash IVF Group. Before that position he was an Executive at Cochlear Limited, serving as Chief Strategy Officer, having previously been President of Cochlear Bone Anchored Solution, and Senior Vice President of Business Development.
Prior to joining Cochlear Limited, David worked at Accenture in the Strategy practice. He also has extensive Australian and International experience in consumer products, utilities and financial services.
David has a Bachelor of Business and a Bachelor of Applied Science from Monash University in Melbourne, Australia. David completed the Advanced Business Management Program at Kellogg School of Management, Northwestern University in Chicago, USA, and is a Graduate of the Australian Institute of Company Directors.
David was elected to the board of JewishCare in 2014.